From Undetectable Equals Untransmittable (U=U) to Breastfeeding: Is the Jump Short?

Background: Vertical transmission of HIV infection may occur during pregnancy, at childbirth or through breastfeeding. Recommendations on the safety of breastfeeding of HIV-infected women on effective antiretroviral treatment are not univocal among international guidelines (WHO 2010, EACS 2017, DHHS 2017), leaving space for variability at the patient’s level. Methods: We collected clinical, laboratory and outcome data from 13 HIV-infected pregnant women who, between March 2017 and June 2021, elected to breastfeed their children against specific medical advice. All mothers were on antiretroviral therapy with darunavir or raltegravir plus emtricitabine/tenofovir disoproxil and remained HIV-RNA undetectable and >400 cells/mmc CD4+ lymphocytes during pregnancy and breastfeeding. Prophylactic antiretroviral therapy (zidovudine for 4 weeks) was started immediately after birth in all newborns. The mean duration of breastfeeding was 5.4 months. Newborns were tested for HIV-RNA multiple times: at birth, 1, 3, and 6 months after birth, and 1, 3 and 6 months after the end of breastfeeding. Results: None of the infants were infected by HIV. Conclusions: Our experience, gathered in the setting of freedom of choice on the patient’s side, while insufficient to address the eventual safety of breastfeeding in HIV-infected mothers since the represented cohort is numerically irrelevant, supports the extension of the U=U (Undetectable Equals Untransmittable) paradigm to this setting. Since breastfeeding is often requested by women with HIV planning pregnancy, more extensive comparative studies should be performed.

[1]  S. Vermeersch,et al.  A public health value-based healthcare paradigm for HIV , 2021, BMC Health Services Research.

[2]  Ingrid A. Beck,et al.  Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component , 2021, Journal of acquired immune deficiency syndromes.

[3]  A. Argo,et al.  Guidelines and Current Assessment of Health Care Responsibility in Italy , 2020, Risk management and healthcare policy.

[4]  P. Ward,et al.  A realist review of infant feeding counselling to increase exclusive breastfeeding by HIV-positive women in sub Saharan-Africa: what works for whom and in what contexts , 2019, BMC Public Health.

[5]  L. Mofenson,et al.  Infectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants: Results From the HPTN 040/PACTG 1043 Trial , 2018, The Pediatric infectious disease journal.

[6]  N. Low,et al.  Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings. , 2018, The lancet. HIV.

[7]  M. Battegay,et al.  Brief Report: No HIV Transmission From Virally Suppressed Mothers During Breastfeeding in Rural Tanzania , 2018, Journal of Acquired Immune Deficiency Syndromes.

[8]  P. Vernazza,et al.  Is breastfeeding an equipoise option in effectively treated HIV-infected mothers in a high-income setting? , 2018, Swiss medical weekly.

[9]  T. Clasen,et al.  Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta‐analysis and meta‐regression , 2018, Tropical medicine & international health : TM & IH.

[10]  H. Coovadia,et al.  Pre-exposure prophylaxis for infants exposed to HIV through breast feeding , 2017, British Medical Journal.

[11]  N. Rollins,et al.  Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis , 2017, Journal of the International AIDS Society.

[12]  B. Chi,et al.  Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. , 2016, The New England journal of medicine.

[13]  L. Haddad,et al.  Management of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential Practices , 2016, Infectious diseases in obstetrics and gynecology.

[14]  S. Tariq,et al.  “It pains me because as a woman you have to breastfeed your baby”: decision-making about infant feeding among African women living with HIV in the UK , 2016, Sexually Transmitted Infections.

[15]  A. Berrebi,et al.  No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  A. Anglemyer,et al.  Antiretroviral interventions for preventing breast milk transmission of HIV. , 2014, The Cochrane database of systematic reviews.

[17]  M. Cortina-Borja,et al.  Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011 , 2014, AIDS.

[18]  K. Atkin,et al.  The impact of transnational migration on intergenerational transmission of knowledge and practice related to breast feeding. , 2014, Midwifery.

[19]  N. Rollins,et al.  Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models , 2012, Sexually Transmitted Infections.

[20]  W. Fawzi,et al.  Exclusive breastfeeding reduces risk of mortality in infants up to 6 mo of age born to HIV-positive Tanzanian women. , 2012, The American journal of clinical nutrition.

[21]  J. Currier,et al.  Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa , 2010, Journal of acquired immune deficiency syndromes.

[22]  J. Tappero,et al.  Breastfeeding, Mother-to-Child HIV Transmission, and Mortality Among Infants Born to HIV-Infected Women on Highly Active Antiretroviral Therapy in Rural Uganda , 2010, Journal of Acquired Immune Deficiency Syndromes.

[23]  L. Kuhn,et al.  Breastfeeding and AIDS in the developing world , 2009, Current opinion in pediatrics.

[24]  Peter B Gilbert,et al.  Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. , 2006, JAMA.

[25]  R. Brookmeyer,et al.  Replacement-fed infants born to HIV-infected mothers in India have a high early postpartum rate of hospitalization. , 2003, The Journal of nutrition.

[26]  R. Reading,et al.  Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis , 2000 .

[27]  Dorothy Bray,et al.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.

[28]  J. Karon,et al.  Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial , 1999, The Lancet.

[29]  J. Karon,et al.  Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial , 1999, The Lancet.

[30]  L. Kuhn,et al.  Infant survival, HIV infection, and feeding alternatives in less-developed countries. , 1997, American journal of public health.

[31]  Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with , 2017 .

[32]  Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV , 2017 .

[33]  E. Piwoz,et al.  HIV and Infant Feeding : , 2006 .

[34]  L. van der Merwe,et al.  Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. , 2002, The Cochrane database of systematic reviews.